Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Similar documents
Dermovate Scalp Application clobetasol propionate

Dermovate Scalp Application clobetasol propionate

Package Leaflet: Information for the User

Eumovate Cream clobetasone butyrate

Dermovate Ointment clobetasol propionate

Eumovate Ointment clobetasone butyrate

Dermovate Ointment clobetasol propionate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

Daktacort 2% / 1% w/w cream

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

Retin-A 0.05% w/w cream

PATIENT INFORMATION LEAFLET. Timodine Cream

Occlusal 26%w/w cutaneous solution salicylic acid

O N C E A DAY. In this leaflet FOR WOMEN

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

DP Fusidic Acid Cream

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Hair Loss Treatment Regular Strength (Minoxidil)

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

1 What Gyno-Daktarin cream is and what it is used for

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

ISOTREX GEL Isotretinoin 0.05% w/w

EUMOVATE Clobetasone butyrate 0.05% w/w cream

WOMEN'S Regaine EXTRA STRENGTH

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

SIGMACORT cream and ointment

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

Daivobet 50/500 gel Dye-vo-bet

v MM 130.2MM FOR WOME N O N C E A D AY

Dalacin V Cream Clindamycin phosphate

ACETOCAUSTIN 0,5 ml, Cutaneous solution

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

CONSUMER MEDICINE INFORMATION

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

A guide for patients who have been prescribed Stelara

Information PROPECIA Finasteride 1mg Tablet

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

Patient Information Leaflet. Dermal Filler

Procedure/ Care Plan for Domiciliary Care Workers/ Support Workers - Application of Prescribed Creams/ Ointments/ Lotions (Adult)

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

EMOLLIENTS. NEW 500g NEW. pump. Up to 37% Wider choice, greater savings! cost savings. without compromising on quality or patient care!

Instructions for use. Ixekizumab

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

Figure A. Figure B To prevent premature activation of the needle safety guard, do not touch the NEEDLE GUARD ACTIVATION CLIPS at any time during use.

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Administering ORENCIA (abatacept): Your Step-by-Step Guide

Taking Care of Your Skin During Radiation Therapy

Instructions For Use PRALUENT (PRAHL-u-ent) (alirocumab) Injection, for Subcutaneous Injection Single-Dose Pre-Filled Pen (75 mg/ml)

Skin Care During Radiation Therapy

Emollient Prescribing Guidelines

Skin Reactions from Radiation Treatments

PUVA (Psoralen + ultra violet light - wavelength A)

Instructions For Use

PUVA (Psoralen + ultra violet light - wavelength A)

You and your scalp. Helpful hints and advice on treating Dry Scaly Scalp Conditions

The Leeds Teaching Hospitals NHS Trust Whole body PUVA treatment with oral psoralen

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

Psoralen Tablets (Methoxypsoralen)

headlice the facts and myths everyone s essential guide

Wound care and treatment Burns (1st, 2nd and 3rd degree burns) Sunburn

Care of your skin. Introduction. What can you do to help? Step 1 - Hygiene. Patient Information

Hand and foot PUVA (Psoralen + ultra violet light - wavelength A)

TECHNICAL DATA SHEET

Head lice. What they are, how to spot them and how to treat them. Facts about head lice.

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

Transcription:

Package Leaflet: Information for the User Betnovate Scalp Application betamethasone valerate Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1 What Betnovate is and what it is used for 2 What you need to know before you use Betnovate 3 How to use Betnovate 4 Possible side effects 5 How to store Betnovate 6 Contents of the pack and other information 1 What Betnovate is and what it is used for Betnovate Scalp Application (called Betnovate in this leaflet) contains a medicine called betamethasone valerate. It belongs to a group of medicines called steroids that help to reduce swelling and irritation. Betnovate is used to help reduce the redness and itchiness of certain scalp problems, such as psoriasis and dermatitis. 2 What you need to know before you use Betnovate Do not use Betnovate: if you are allergic (hypersensitive) to betamethasone valerate or any of the other ingredients of Betnovate (listed in Section 6) if you have a skin infection on your scalp on a child under 1 year. Do not use Betnovate if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before using Betnovate. Warnings and precautions Talk to your doctor or pharmacist before you use this medicine if: you have previously had an allergic reaction with another steroid you are applying the liquid under an airtight dressing. These dressings make it easier for the active ingredient to pass through the skin. It is possible to accidentally end up using too much you have psoriasis, your doctor will want to see you more often you are applying the liquid to broken skin or within the skin folds you are applying to a large surface area

you are applying to thin skin or on children as their skin is thinner than adults and as a result may absorb larger amounts. Dressing or bandages should not be used on children where the scalp application is applied. Use on children should be limited to 5 days. Contact your doctor if you experience blurred vision or other visual disturbances. If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before using this medicine. Other medicines and Betnovate Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine, especially if you are taking ritonavir and itraconazole medications. Pregnancy and breast-feeding and fertility If you are pregnant or are breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. 3 How to use Betnovate Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Using this medicine You usually put Betnovate on your scalp in the morning and at night. This may be reduced as your scalp problem begins to get better. Do not use Betnovate more often than prescribed. Do not use it for a long time (such as every day for many weeks or months) - unless your doctor tells you to. Be very careful not to get the liquid in your eyes. Do not touch your eyes until you have washed your hands. If you wash or shampoo your hair it should be dried before applying the liquid. If you are applying Betnovate on someone else make sure you wash your hands after use or wear disposable plastic gloves. Do not dry your hair with a hairdryer. This product is flammable. Keep the liquid away from open fires and flames and all sources of ignition including smoking during application and immediately after use. Guidance on how to apply the liquid 1 Wash your hands. 2 Unscrew the bottle cap and place the nozzle on the scalp that needs treating. 3 Gently squeeze the bottle to cover the area with a thin and even layer of liquid. 4 You can rub this liquid in, but you don t have to. 5 Your scalp will feel cool until the liquid has dried. 6 Wash your hands again. 7 It is important not to exceed the prescribed amount.

If you use more Betnovate than you should If you apply too much or if accidentally swallowed, it could make you ill. Talk to your doctor or go to the hospital as soon as possible. If you forget to use Betnovate If you forget to apply Betnovate, apply it as soon as you remember. If it is close to the time you are next meant to apply it you can wait until this time. If you stop using Betnovate If you use Betnovate regularly make sure you talk to your doctor before you stop using it as your condition may get worse if stopped suddenly. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4 Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. Stop using Betnovate and tell your doctor immediately if: you find that your skin condition gets worse, you develop a generalised rash or your skin becomes swollen during treatment. You may be allergic to Betnovate, have an infection or need other treatment. you have psoriasis and get raised bumps with pus under the skin. This can happen very rarely during or after treatment and is known as pustular psoriasis. Other side effects you may notice when using Betnovate include: Common (may affect up to 1 in 10 people) a feeling of burning, pain, irritation or itching where the liquid is applied. Very rare (may affect up to 1 in 10,000 people) an increased risk of infection an allergic skin reaction where the liquid is applied rash, itchy bumpy skin or redness of the skin thinning and dryness of your skin and it may also damage or wrinkle more easily stretch marks may develop veins under the surface of your skin may become more noticeable an increase or reduction in hair growth or hair loss and changes in skin colour weight gain, rounding of the face delayed weight gain or slowing of growth in children bones can become thin, weak and break easily cloudy lens in the eye (cataract) or increased pressure in eye (glaucoma) increased blood sugar levels or sugar in the urine high blood pressure Not Known (frequency cannot be estimated from the available data) blurred vision

Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine. 5 How to store Betnovate Keep out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle label or carton after (Exp). The expiry date refers to the last day of that month. Do not store above 25 C. Keep the container tightly closed when not in use. Contents are flammable. Keep Betnovate Scalp Application away from all sources of fire, flame and heat. Do not leave Betnovate Scalp Application in direct sunlight. Do not throw away medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6 Contents of the pack and other information What Betnovate contains The active ingredient is betamethasone valerate. Each 10 ml contains 0.01 ml of betamethasone (0.1 % w/w) as valerate. The other ingredients are carbomer, isopropyl alcohol, sodium hydroxide and purified water. What Betnovate looks like and contents of the pack Within each carton is a specially designed plastic bottle with a nozzle and cap that contains 100 ml of a sticky liquid. Marketing Authorisation Holder and Manufacturer Product licence held by Glaxo Wellcome UK Ltd, Stockley Park West, Uxbridge, Middlesex UB11 1BT Manufactured by Aspen Bad Oldesloe GmbH Industriestrasse 32-36 23843 Bad Oldesloe Germany More Information If you have any questions or are not sure about anything, ask your doctor or pharmacist who will advise you. You may be able to find out more information from books in public libraries.

Other formats To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK Only) Please be ready to give the following information: Product name Betnovate Scalp Application Reference number 10949/0045 This is a service provided by the Royal National Institute of Blind People. This leaflet was last revised in September 2017. Trade marks are owned by or licensed to the GSK group of companies. 2017 GSK group of companies or its licensor.